Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJun 28, 2026
DataAggregated Company Financials
Companies7
- 7D4.5%
- 3M13.7%
- 1Y-8.1%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 4.5%, driven by gains from Oxford Nanopore Technologies of 6.5%. During this same period, the hVIVO underperformed, falling 12%. However, the industry is down 8.1% over the past year. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 28 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1265.7x | -8.5x | 4.4x |
| Tue, 26 May 2026 | UK£1.5b | UK£318.9m | -UK£167,635,254.00 | n/a | -9x | 4.7x |
| Thu, 23 Apr 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.5x | 4.4x |
| Sat, 21 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 8.9x | -8.5x | 4.2x |
| Mon, 16 Feb 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 10.9x | -9.8x | 5.1x |
| Wed, 14 Jan 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 8.4x | -10.5x | 5.5x |
| Fri, 12 Dec 2025 | UK£1.5b | UK£304.4m | -UK£160,881,254.00 | 6.2x | -9.1x | 4.8x |
| Sun, 09 Nov 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.2x | -9.6x | 5.2x |
| Tue, 07 Oct 2025 | UK£1.7b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -10.5x | 5.6x |
| Thu, 04 Sep 2025 | UK£1.8b | UK£313.4m | -UK£158,068,352.00 | 6.5x | -11.4x | 5.8x |
| Sat, 02 Aug 2025 | UK£2.1b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.3x | 7.3x |
| Mon, 30 Jun 2025 | UK£1.5b | UK£291.6m | -UK£159,942,352.00 | 7x | -9.5x | 5.2x |
| Wed, 28 May 2025 | UK£1.7b | UK£319.5m | -UK£190,886,593.30 | 10.2x | -8.9x | 5.3x |
| Fri, 25 Apr 2025 | UK£1.6b | UK£314.8m | -UK£185,527,748.80 | 6.4x | -8.8x | 5.2x |
| Sun, 23 Mar 2025 | UK£1.6b | UK£315.6m | -UK£186,234,564.20 | 6x | -8.5x | 5x |
| Tue, 18 Feb 2025 | UK£1.8b | UK£306.5m | -UK£195,184,786.80 | 7x | -9.4x | 6x |
| Thu, 16 Jan 2025 | UK£2.1b | UK£307.7m | -UK£196,108,205.04 | 7x | -10.5x | 6.7x |
| Sat, 14 Dec 2024 | UK£2.1b | UK£306.4m | -UK£195,146,906.64 | 8.5x | -10.8x | 6.9x |
| Mon, 11 Nov 2024 | UK£1.9b | UK£304.9m | -UK£192,889,229.20 | 10.6x | -9.8x | 6.2x |
| Wed, 09 Oct 2024 | UK£2.1b | UK£304.3m | -UK£192,277,551.10 | 10.2x | -10.8x | 6.8x |
| Fri, 06 Sep 2024 | UK£2.0b | UK£293.7m | -UK£192,851,130.20 | 12.2x | -10.3x | 6.8x |
| Sun, 04 Aug 2024 | UK£1.8b | UK£295.5m | -UK£189,945,748.23 | 12.6x | -9.7x | 6.2x |
| Tue, 02 Jul 2024 | UK£1.5b | UK£296.0m | -UK£190,319,462.97 | 11.4x | -8x | 5.1x |
| Thu, 30 May 2024 | UK£1.6b | UK£295.7m | -UK£189,881,687.55 | 11.4x | -8.5x | 5.4x |
| Sat, 27 Apr 2024 | UK£1.5b | UK£317.6m | -UK£178,454,345.45 | 11.9x | -8.3x | 4.7x |
| Mon, 25 Mar 2024 | UK£1.8b | UK£296.0m | -UK£213,289,739.77 | 7353.2x | -8.6x | 6.2x |
| Wed, 21 Feb 2024 | UK£1.9b | UK£285.9m | -UK£189,315,420.21 | 6962.3x | -10.1x | 6.7x |
| Fri, 19 Jan 2024 | UK£2.9b | UK£450.2m | -UK£176,598,755.00 | 60.7x | -16.3x | 6.4x |
| Sun, 17 Dec 2023 | UK£3.1b | UK£450.1m | -UK£174,093,562.00 | 54.8x | -17.7x | 6.8x |
| Tue, 14 Nov 2023 | UK£3.0b | UK£456.3m | -UK£169,339,120.00 | 47.7x | -17.7x | 6.6x |
| Thu, 12 Oct 2023 | UK£3.0b | UK£458.3m | -UK£165,334,304.00 | 53.2x | -18x | 6.5x |
| Sat, 09 Sep 2023 | UK£3.1b | UK£440.4m | -UK£166,946,001.00 | 69.6x | -18.6x | 7x |
| Mon, 07 Aug 2023 | UK£3.4b | UK£476.5m | -UK£124,704,061.00 | 70.6x | -27.1x | 7.1x |
| Wed, 05 Jul 2023 | UK£2.9b | UK£476.6m | -UK£124,755,108.00 | 66.1x | -23.6x | 6.2x |
Price to Earnings Ratio
-23.6x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.14% | |
| Healthcare | 6.15% | |
| Life Sciences | 4.55% | |
| Clinical Research and Equipment | 4.55% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.24 | 6.5% +UK£73.9m | -8.5% | PS5.4x | |
| PRM Proteome Sciences | UK£0.017 | 13.6% +UK£719.0k | -43.8% | PS1.6x |